Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 86

Results For "EY"

5016 News Found

Experts convene in India to push for urgent action on dengue treatment gaps
Public Health | April 23, 2026

Experts convene in India to push for urgent action on dengue treatment gaps

Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches


Japanese pharma firms turn to CDMOs early as peptide complexity rises
News | April 23, 2026

Japanese pharma firms turn to CDMOs early as peptide complexity rises

Neuland Laboratories reported an uptick in peptide-related engagements from Japanese companies, particularly at the preclinical and early clinical stages


Lupin launches Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in USA
Drug Approval | April 23, 2026

Lupin launches Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in USA

The product is approved as bioequivalent to Xigduo XR for the indications outlined in the reference drug’s labelling


Vice-President calls for integrity in medical practice at AIIMS Rishikesh convocation
Hospitals | April 23, 2026

Vice-President calls for integrity in medical practice at AIIMS Rishikesh convocation

C. P. Radhakrishnan urged graduates to uphold ethical standards and maintain a commitment to patient care


We believe in trust-driven clinical conversations to cut through medical misinformation: Saurav Kasera, Founder, CLIRNET
interviews | April 22, 2026

We believe in trust-driven clinical conversations to cut through medical misinformation: Saurav Kasera, Founder, CLIRNET

CLIRNET plans to expand globally and improve how medical knowledge is shared and used in practice


HCL Healthcare opens Bengaluru office to deepen enterprise client engagement
Healthcare | April 22, 2026

HCL Healthcare opens Bengaluru office to deepen enterprise client engagement

New regional hub strengthens presence in a key market and enhances service delivery for corporate healthcare clients


Zyax Chem takes 26% stake in Gaymed Labs
News | April 22, 2026

Zyax Chem takes 26% stake in Gaymed Labs

Targets high-growth eye care expansion push


Ultomiris shows strong interim results in Phase III IgA nephropathy trial
Clinical Trials | April 22, 2026

Ultomiris shows strong interim results in Phase III IgA nephropathy trial

IgAN is a rare, progressive kidney disease driven by abnormal IgA immune complexes that deposit in the kidneys


Crown Bioscience partners with Turbine to accelerate translational oncology research
R&D | April 22, 2026

Crown Bioscience partners with Turbine to accelerate translational oncology research

The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems


ProBioGen appoints Dr Simon Johannes Bulling as its new Chief Operating Officer
People | April 22, 2026

ProBioGen appoints Dr Simon Johannes Bulling as its new Chief Operating Officer

Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations